Wednesday, June 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “polysaccharide” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 9
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 9 pipeline programs matching "polysaccharide" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

9 results for “polysaccharide” Back to intelligence hub

Search results

  1. MEQ00074

    Sanofi Pasteur

    Meningococcal Infection

    phase 3 mab completed

    1 trial
  2. MET55

    Sanofi Pasteur

    Meningococcal Immunization

    phase 3 mab completed

    1 trial
  3. NL79088.041.21

    Disc Medicine

    Primary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)

    phase 3 small molecule active

    1 trial
  4. mucoid exopolysaccharide P. aeruginosa immune globulin IV

    Ultragenyx UK Limited

    Cystic Fibrosis

    phase 2 small molecule completed

    1 trial
  5. pneumococcal polysaccharide and protein conjugate vaccines

    United Therapeutics Europe Ltd

    Pneumococcal Infections

    phase 2 mab completed

    1 trial
  6. Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    phase 1 mab completed

    1 trial
  7. Meningococcal ACYW135 Polysaccharide Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Meningitis, Meningococcal

    phase 1 mab active

    1 trial
  8. domestic polysaccharide superparamagnetic iron oxide nanoparticle

    The First People's Hospital of Lianyungang

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial
  9. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.